SpringWorks Therapeutics (SWTX) is the lead sponsor of 6 active clinical trials listed on ClinicalTrials.gov[4], including 2 Phase 2[1], 3 Phase 1[2], 1 Phase 4[3].
No Form 4 insider filings for SWTX were recorded at the SEC in the past 30 days[5].
SWTX is tracked by BiotechSigns with a current catalyst score of 40/100 and grade D. The page summarizes 0 active signals, including 0 PDUFA, 0 insider buying, and 0 clinical trial signals, with data refreshed on 2026-06-03.
SpringWorks Therapeutics (SWTX) is the lead sponsor of 6 active clinical trials listed on ClinicalTrials.gov[4], including 2 Phase 2[1], 3 Phase 1[2], 1 Phase 4[3].
No Form 4 insider filings for SWTX were recorded at the SEC in the past 30 days[5].